Selected Targets. During the applicable Selection Period, ▇▇▇▇▇ shall have the right to select from the Reserved Targets: (a) up to [***] Other Hepatocyte Cardiometabolic Targets; (b) up to [***] Non-Hepatocyte Cardiometabolic Targets; and (c) such initial Non-Hepatocyte Neurodegeneration/Pain Targets as may be selected by ▇▇▇▇▇, plus such additional Targets as may be recommended by ▇▇▇▇▇ and accepted by the JSC.
Appears in 2 contracts
Sources: Collaboration and License Agreement (Dicerna Pharmaceuticals Inc), Collaboration and Licensing Agreement